Orchestra BioMed Holdings, Inc.
Regulated industryPhysical productsSells to businessesDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $6.97
- 52-Week Range
- $3.46 – $7.83
- Market Cap
- $587.14M
- P/E (TTM)
- —
- EPS (TTM)
- -0.75
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 58.74
- PEG Ratio
- —
- Return on Equity
- -182.29%
- Return on Assets
- -35.86%
- Gross Margin
- 99.56%
- Operating Margin
- -195.39%
- Profit Margin
- -182.50%
- Current Ratio
- 7.25
- Debt/Equity
- 3.92
- Total Debt
- $73.54M
- Free Cash Flow
- $-37.93M
- Revenue Growth
- -89.40%
- Earnings Growth
- —
- Enterprise Value
- $569.74M
Market Snapshot
About
Orchestra BioMed Holdings, Inc. develops biomedical innovations focused on treating cardiovascular and vascular diseases with novel medical devices and therapies.